WO2011079806A1 - Self-expanding stent - Google Patents

Self-expanding stent Download PDF

Info

Publication number
WO2011079806A1
WO2011079806A1 PCT/CN2010/080504 CN2010080504W WO2011079806A1 WO 2011079806 A1 WO2011079806 A1 WO 2011079806A1 CN 2010080504 W CN2010080504 W CN 2010080504W WO 2011079806 A1 WO2011079806 A1 WO 2011079806A1
Authority
WO
WIPO (PCT)
Prior art keywords
self
stent
drug
layer
expanding stent
Prior art date
Application number
PCT/CN2010/080504
Other languages
French (fr)
Chinese (zh)
Inventor
罗七一
李�雨
谢志永
金巧蓉
王森
Original Assignee
微创医疗器械(上海)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 微创医疗器械(上海)有限公司 filed Critical 微创医疗器械(上海)有限公司
Publication of WO2011079806A1 publication Critical patent/WO2011079806A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body

Definitions

  • the present invention relates to the field of medical device technology, and more particularly to a self-expanding stent.
  • Intracranial atherosclerotic stenosis is an important cause of ischemic stroke, which is caused by up to 33% of strokes in China, and more than 50% of transient cerebral ischemia (TIA) is related to it.
  • TIA transient cerebral ischemia
  • 1 is a cerebral artery
  • 2 is a cerebral artery stenosis plaque. Because cerebral artery 1 produces lesions of cerebral artery stenosis 2, it is easy to cause transient cerebral hypoxia (TIA) and die.
  • TIA transient cerebral hypoxia
  • Intracranial arterial stenosis occurs mainly at the bifurcation of the aortic bifurcation, such as the beginning of the internal carotid artery and the siphon, the trunk of the middle cerebral artery, the basilar artery, the beginning of the artery, and the cranium.
  • Cerebral artery stenosis has always been a difficult point in clinical treatment.
  • Traditional medical drug treatment studies have failed due to higher ischemic stroke (including TIA and cerebral infarction) and mortality; and surgical treatment - clinical results of intracranial and extracranial bypass surgery have shown intracranial and extracranial vascular bypass surgery for intracranial stenosis Or occlusion is ineffective, especially in patients with stenosis or occlusion of the middle cerebral artery.
  • Endovascular treatment has opened up new treatments for intracranial stenosis.
  • Neurologists have used the experience of interventional treatment of coronary artery stenosis to try angioplasty and stent implantation for intracranial artery stenosis.
  • the coronary stents used in earlier studies were not satisfactory enough.
  • the coronary catheter and stent material cannot pass through the curved part of the intracranial artery, especially the siphon segment of the internal carotid artery; the anatomy of the intracranial artery is more distorted, the lumen is thinner, and the diameter of the tube is larger than that of the coronary artery. It lacks support around it and is suspended in the cerebrospinal fluid.
  • American company boston developed a self-expanding stent designed for the softening of the open-loop stent for the characteristics of the intracranial artery. However, due to its developmental structure, the support force is uneven.
  • the extension of the rod at the vessel to the vessel wall causes mechanical irritation and stenosis to the lumen of the vessel, as well as tissue hyperplasia caused after implantation.
  • the stent has a clinically high rate of restenosis.
  • the present invention provides a self-expanding stent to solve the problem of uneven support force of the self-expanding stent of the ring design, and to avoid tissue hyperplasia and restenosis caused after implantation.
  • the present invention provides the following technical solutions:
  • a self-expanding stent which is a hollow tubular mesh structure
  • Each of the bracket members can form a closed mesh with an adjacent bracket member.
  • the mesh has a polygonal structure.
  • the mesh is a three-, four-, five- or six-sided structure.
  • the mesh is an equilateral polygonal structure.
  • the mesh has a length along the axial direction of the bracket that is smaller than a radial length along the bracket.
  • the self-expanding stent described above employs an elastic memory material.
  • the self-expanding stent is made of a temperature-sensitive memory alloy material.
  • the outer surface of the stent rod facing the blood vessel wall is provided with a drug layer.
  • the stent rod member is provided with a drug-loading groove facing the outer surface of the blood vessel wall;
  • the drug layer is disposed in the drug loading tank.
  • the drug layer specifically comprises a bonding layer, a drug-loading coating layer and a surface encapsulating layer;
  • the bonding layer is located at the bottom of the drug layer
  • the drug loading layer is located at an upper portion of the bonding layer;
  • the surface encapsulation layer is located at an upper portion of the drug-loading layer, and an outer surface thereof is flush with a surface of the stent.
  • the bonding layer has a micro-nano uneven structure.
  • the drug-loading layer is a drug capable of inhibiting proliferation of a degradable polymer blend.
  • the surface encapsulating layer is a hydrophilic lubricating coating.
  • the drug-loading tank is a single groove along the rod, a plurality of grooves along the rod or a plurality of grooves of the vertical rod.
  • the above self-expanding stent is used in a cerebral artery.
  • the cerebral vascular stent in the embodiment of the present invention has a hollow tubular shape and a uniform mesh structure, which is transported to the cerebral vascular lesion, and the stenosis lesion is released through the delivery rod, the lesion is expanded, and the vascular flow channel is reconstructed. Since the structure is designed as a uniformly continuous mesh structure, each rod can form a closed mesh with adjacent rods, uniformly and continuously covering the narrow plaques, providing a uniform annular support force, especially in curved At the vessel, closure can form a continuous lumen channel.
  • Figure 1 is a schematic diagram of cerebral artery stenosis
  • FIG. 2 is a schematic view of a self-expanding stent implanted in a cerebral artery according to an embodiment of the present invention
  • FIG. 3 is a partial enlarged view of a self-expanding stent according to an embodiment of the present invention. Schematic;
  • FIG. 5 is a schematic structural view of a drug-loading tank according to an embodiment of the present invention
  • FIG. 6 is a schematic structural view of a three drug loading tank according to an embodiment of the present invention
  • FIG. 5 is a schematic structural view of a drug-loading tank according to an embodiment of the present invention
  • FIG. 6 is a schematic structural view of a three drug loading tank according to an embodiment of the present invention
  • FIG. 7 is a schematic structural view of a drug loading layer according to an embodiment of the present invention.
  • the present invention discloses a self-expanding stent to solve the problem of uneven support of the self-expanding stent of the ring design, and to avoid tissue hyperplasia and restenosis caused by implantation.
  • FIG. 2 is a schematic diagram of a self-expanding stent implanted in a cerebral artery according to an embodiment of the present invention
  • FIG. 3 is a partial enlarged view of the self-expanding stent according to an embodiment of the present invention.
  • 3 is a self-expanding stent
  • 31 is a mesh
  • 32 is a stent rod.
  • the self-expanding stent 3 provided by the invention is a hollow tubular mesh structure
  • bracket member 32 Around the mesh 31 is a bracket member 32;
  • Each of the bracket members 32 can form a closed mesh 31 with an adjacent bracket member.
  • the stent is a uniformly continuous closed mesh structure, uniformly and continuously covering the narrow plaque, providing a uniform annular supporting force, especially at the curved blood vessel, and closing can form a continuous lumen channel, overcoming the open loop structure
  • the extension of the rod to the vessel wall at the bend causes mechanical stimulation and bulging into the lumen of the vessel causing restenosis.
  • the structure of the single closed mesh 31 may be a polygon, and the optimized selection is three, four, five or hexagonal, and further, in order to make the force more uniform, the mesh 31 is equilateral.
  • the length of the mesh 31 along the axial direction of the stent 3 is smaller than the radial length along the stent 3, which is advantageous for maintaining the circular lumen passage of the stent 3 at the curved blood vessel.
  • the material of the bracket 3 is made of an elastic memory material, and further may be a temperature-sensitive memory alloy.
  • the temperature-sensitive elastic polymer which can be bound to a micro-single lumen, is delivered to the target lesion for release and can be restored to its pre-constrained size at body temperature.
  • the stent 3 for treating cerebrovascular stenosis disclosed in the present invention has an open tubular shape and a uniform mesh structure; the stent adopts an elastic memory material and can be compressed and bound in a micro single lumen tube, and is transported to At the cerebral vascular lesion, the stenotic lesion is released through the delivery rod, the lesion is expanded, and the vascular flow channel is reconstructed; the unilateral outer layer of the stent has a drug-loading layer, and the drug is released into the blood vessel wall to inhibit restenosis.
  • a uniformly closed mesh structure each of the rods can form a closed mesh with the adjacent rods, and the hooks continuously cover the narrow plaques, providing a uniform annular supporting force, especially at the curved blood vessels.
  • the closure can form a continuous lumen channel, overcoming the developmental structure causing mechanical stimulation at the bending of the rod to the vessel wall and causing stenosis to protrude into the lumen of the vessel.
  • FIG. 4 is a schematic structural view of a drug-loading tank according to an embodiment of the present invention
  • FIG. 5 is a schematic structural view of a drug-loading tank provided by an embodiment of the present invention
  • FIG. 6 is a drug-loading provided by an embodiment of the present invention
  • FIG. 7 is a schematic structural view of a drug loading layer according to an embodiment of the present invention.
  • 321 is the base of the drug-loading tank
  • 4 is a drug-loading tank structure
  • 41 is a surface encapsulating layer
  • 42 is a drug-loading coating layer
  • 43 is a bonding layer.
  • the outer surface of the stent rod facing the blood vessel wall is provided with a drug-loading groove; wherein the drug-loading groove structure 4 can be a single groove along the axial direction of the stent rod, and a plurality of grooves along the axial direction of the stent rod member, perpendicular to the stent rod member Multiple slots.
  • a drug layer is disposed in the drug loading tank.
  • the drug layer specifically includes a bonding layer 43, a drug-loading coating layer 42 and a surface encapsulating layer 41;
  • the bonding layer 43 is located at the bottom of the drug layer, that is, on the drug carrier base 321; the drug loading layer 42 is located at the upper portion of the bonding layer 43;
  • the surface encapsulation layer 41 is located at an upper portion of the drug-loading layer 42 and has an outer surface that is flush with the surface of the support.
  • the drug layer is used to release the drug into the targeted vessel wall to inhibit smooth muscle hyperplasia.
  • the inner surface of the stent in contact with the blood is still the scaffold matrix material, which has very good blood compatibility and avoids thrombus and endothelium caused by the drug coating. Barriers.
  • the drug-loading layer 42 is partially recessed into the surface of the stent to overcome the frictional contact between the outer wall of the stent and the inner wall of the tube when the self-expanding stent is transported in the single-lumen tube, thereby causing damage or falling off of the drug-loading layer.
  • the drug layer is evenly distributed on the stent rod to form a uniform coverage space covering the vessel wall.
  • the bonding layer 43 at the bottom of the drug layer has a micro-nano uneven structure, such as a hole or matrics result, for the purpose of enhancing the adhesion of the drug-loading layer 42 on the drug-carrying base 321; the drug-loading layer 42 located at the upper portion of the bonding layer 43 is used.
  • the degradable polymer blend inhibits the proliferation of the drug;
  • the surface encapsulating layer 41 located on the upper portion of the drug-loading layer 42 is a hydrophilic lubricating coating to reduce the friction between the outer layer and the inner layer of the transporting single-chamber tube, and provide the conveying ability
  • the surface encapsulation layer 41 is fused in the tissue fluid to expose the drug-loaded coating 42.
  • the invention is mainly used for the problem of blood vessel stenosis caused by vascular disease, and is especially suitable for stenosis of brain arteries.

Abstract

A self-expanding stent (3) includes a tubular body, and hollowed-out meshes (31) are formed in the tubular body. Stent bar members (32) surround the meshes (31). Each of stent bar members (32) forms a closed mesh (31) with adjacent stent bar member (32) so as to uniformly and continuously cover plaque at stenosis and provide uniform and annular support force for lumen.

Description

自扩张支架  Self-expanding stent
技术领域 本发明涉及医疗器械技术领域, 更具体地说, 涉及一种自扩张支 架。 TECHNICAL FIELD The present invention relates to the field of medical device technology, and more particularly to a self-expanding stent.
背景技术 颅内动脉粥样硬化性狭窄是缺血性脑卒中一个重要致病原因,在 我国高达 33%的脑卒中是其引起的, 大于 50 %以上的短暂性脑缺血 ( TIA ) 与其有关。 如图 1所示, 其中 1为脑动脉, 2为脑动脉狭窄斑 块, 由于脑动脉 1产生脑动脉狭窄斑块 2的病变, 极易导致短暂性脑缺 血( TIA )而死亡。 颅内动脉狭窄主要发生在大动脉分叉部级转折处, 如颈内动脉起始部及虹吸部, 大脑中动脉主干,.基底动脉, 推动脉起 始部及入颅处。 BACKGROUND OF THE INVENTION Intracranial atherosclerotic stenosis is an important cause of ischemic stroke, which is caused by up to 33% of strokes in China, and more than 50% of transient cerebral ischemia (TIA) is related to it. . As shown in Fig. 1, 1 is a cerebral artery, and 2 is a cerebral artery stenosis plaque. Because cerebral artery 1 produces lesions of cerebral artery stenosis 2, it is easy to cause transient cerebral hypoxia (TIA) and die. Intracranial arterial stenosis occurs mainly at the bifurcation of the aortic bifurcation, such as the beginning of the internal carotid artery and the siphon, the trunk of the middle cerebral artery, the basilar artery, the beginning of the artery, and the cranium.
脑动脉狭窄一直是临床治疗的难点。传统的内科药物治疗研究因 有较高缺血性卒中 (包括 TIA和脑梗塞)和死亡率而失败; 而外科治 疗-颅内外动脉搭桥手术临床研究结果显示颅内外血管搭桥手术治疗 颅内动脉狭窄或闭塞是无效的,尤其是在大脑中动脉狭窄或闭塞的患 者。  Cerebral artery stenosis has always been a difficult point in clinical treatment. Traditional medical drug treatment studies have failed due to higher ischemic stroke (including TIA and cerebral infarction) and mortality; and surgical treatment - clinical results of intracranial and extracranial bypass surgery have shown intracranial and extracranial vascular bypass surgery for intracranial stenosis Or occlusion is ineffective, especially in patients with stenosis or occlusion of the middle cerebral artery.
血管内治疗技术为颅内动脉狭窄开创了新的治疗方法,神经科医 师借鉴冠状动脉狭窄介入治疗经验,尝试颅内动脉狭窄的血管成形及 支架植入治疗。 但早期的研究使用的冠脉支架, 其效果还不够令人满 意。 冠脉的导管和支架材料等不能通过颅内动脉弯曲部位, 尤其是颈 内动脉的虹吸段; 颅内动脉的解剖结构相比于冠脉血管走行更迂曲、 管腔纤细、 管径变化大, 且其周围缺乏支撑, 悬浮于脑脊液中。 美国 公司 boston针对颅内动脉的特点开发出专用于颅内动脉支架, 为柔软 的开环设计的自膨胀式支架, 但由于其开发式结构导致支撑力不均,  Endovascular treatment has opened up new treatments for intracranial stenosis. Neurologists have used the experience of interventional treatment of coronary artery stenosis to try angioplasty and stent implantation for intracranial artery stenosis. However, the coronary stents used in earlier studies were not satisfactory enough. The coronary catheter and stent material cannot pass through the curved part of the intracranial artery, especially the siphon segment of the internal carotid artery; the anatomy of the intracranial artery is more distorted, the lumen is thinner, and the diameter of the tube is larger than that of the coronary artery. It lacks support around it and is suspended in the cerebrospinal fluid. American company boston developed a self-expanding stent designed for the softening of the open-loop stent for the characteristics of the intracranial artery. However, due to its developmental structure, the support force is uneven.
1 在血管弯曲处的杆件向血管壁伸张造成机械刺激及向血管 腔内凸 出造成狭窄, 以及植入后引起的组织增生, 该支架临床具有非常高的 再狭窄率。 1 The extension of the rod at the vessel to the vessel wall causes mechanical irritation and stenosis to the lumen of the vessel, as well as tissue hyperplasia caused after implantation. The stent has a clinically high rate of restenosis.
发明内容 有鉴于此, 本发明提供了一种自扩张支架, 以解决环设计的自膨 胀式支架支撑力不均的问题,避免植入后引起的组织增生和再狭窄出 现。 SUMMARY OF THE INVENTION In view of the above, the present invention provides a self-expanding stent to solve the problem of uneven support force of the self-expanding stent of the ring design, and to avoid tissue hyperplasia and restenosis caused after implantation.
为实现上述目的, 本发明提供如下技术方案:  To achieve the above object, the present invention provides the following technical solutions:
一种自扩张支架, 该支架为镂空管状的网孔结构;  A self-expanding stent, which is a hollow tubular mesh structure;
所述网孔周围为支架杆件;  Around the mesh is a bracket rod;
所述每一个支架杆件都能与相邻支架杆件形成闭合的网孔。 优选的, 上述自扩张支架, 所述网孔为多边形结构。  Each of the bracket members can form a closed mesh with an adjacent bracket member. Preferably, in the self-expanding stent, the mesh has a polygonal structure.
优选的, 上述自扩张支架, 所述网孔为三、 四、五或六边形结构。 优选的, 上述自扩张支架, 所述网孔为等边多边形结构。  Preferably, in the above self-expanding stent, the mesh is a three-, four-, five- or six-sided structure. Preferably, in the self-expanding stent, the mesh is an equilateral polygonal structure.
优选的, 上述自扩张支架, 所述网孔沿支架的轴向长度小于沿支 架的径向长度。 - 优选的, 上述自扩张支架, 该支架采用弹性记忆材料。  Preferably, in the self-expanding stent, the mesh has a length along the axial direction of the bracket that is smaller than a radial length along the bracket. Preferably, the self-expanding stent described above employs an elastic memory material.
优选的, 上述自扩张支架, 该支架釆用温敏性记忆合金材料。 优选的, 上述自扩张支架, 所述支架杆件面向血管壁的外表面设 有药物层。  Preferably, the self-expanding stent is made of a temperature-sensitive memory alloy material. Preferably, in the above self-expanding stent, the outer surface of the stent rod facing the blood vessel wall is provided with a drug layer.
优选的, 上述自扩张支架, 所述支架杆件面向血管壁的外表面设 有载药槽;  Preferably, in the self-expanding stent, the stent rod member is provided with a drug-loading groove facing the outer surface of the blood vessel wall;
所述药物层设于所述载药槽内。  The drug layer is disposed in the drug loading tank.
优选的, 上述自扩张支架, 所述药物层具体包括结合层、 载药涂 层和表面封装层;  Preferably, in the above self-expanding stent, the drug layer specifically comprises a bonding layer, a drug-loading coating layer and a surface encapsulating layer;
所述结合层位于药物层的底部;  The bonding layer is located at the bottom of the drug layer;
所述载药层位于所述结合层的上部; 所述表面封装层位于所述载药层的上部,且其外表面与支架表面 齐平。 The drug loading layer is located at an upper portion of the bonding layer; The surface encapsulation layer is located at an upper portion of the drug-loading layer, and an outer surface thereof is flush with a surface of the stent.
优选的, 上述自扩张支架, 所述结合层具有微纳米不平结构。 优选的, 上述自扩张支架, 所述载药层为可降解高分子共混抑制 增生的药物。  Preferably, in the above self-expanding stent, the bonding layer has a micro-nano uneven structure. Preferably, in the self-expanding stent, the drug-loading layer is a drug capable of inhibiting proliferation of a degradable polymer blend.
优选的, 上述自扩张支架, 所述表面封装层为一种亲水性润滑涂 层。  Preferably, in the above self-expanding stent, the surface encapsulating layer is a hydrophilic lubricating coating.
优选的, 上述自扩张支架, 所述载药槽为沿杆件的单一槽、 沿杆 件的多个槽或垂直杆件的多个槽 。  Preferably, in the self-expanding stent, the drug-loading tank is a single groove along the rod, a plurality of grooves along the rod or a plurality of grooves of the vertical rod.
优选的, 上述自扩张支架, 该支架用于脑动脉中。  Preferably, the above self-expanding stent is used in a cerebral artery.
从上述的技术方案可以看出,本发明实施例中脑血管支架为镂空 管状, 均一网孔结构, 被输送至脑血管病变处, 通过输送杆释放狭窄 病变处, 扩张病变, 重建血管流通道, 由于结构设计为均一连续闭合 的网孔结构, 每一个杆件都能与相邻杆件形成闭合的网孔, 均匀连续 地覆盖狭窄斑块, 提供均一的环状支撑力, 特别是在弯曲的血管处, 闭合能够形成连续的管腔通道。  It can be seen from the above technical solution that the cerebral vascular stent in the embodiment of the present invention has a hollow tubular shape and a uniform mesh structure, which is transported to the cerebral vascular lesion, and the stenosis lesion is released through the delivery rod, the lesion is expanded, and the vascular flow channel is reconstructed. Since the structure is designed as a uniformly continuous mesh structure, each rod can form a closed mesh with adjacent rods, uniformly and continuously covering the narrow plaques, providing a uniform annular support force, especially in curved At the vessel, closure can form a continuous lumen channel.
附图说明 为了更清楚地说明本发明实施例或现有技术中的技术方案,下面 将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而 易见地, 下面描述中的附图仅仅是本发明的一些实施例, 对于本领域 普通技术人员来讲, 在不付出创造性劳动的前提下, 还可以根据这些 附图获得其他的附图。 BRIEF DESCRIPTION OF THE DRAWINGS In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the embodiments or the description of the prior art will be briefly described below, and obviously, in the following description The drawings are only some of the embodiments of the present invention, and those skilled in the art can obtain other drawings based on these drawings without any creative work.
图 1为脑动脉狭窄斑块示意图;  Figure 1 is a schematic diagram of cerebral artery stenosis;
图 2为本发明实施例提供的自扩张支架植入脑动脉中的示意图; 图 3为本发明实施例提供的自扩张支架的局部放大图; 图 4为本发明实施例提供的载药槽一结构示意图;  2 is a schematic view of a self-expanding stent implanted in a cerebral artery according to an embodiment of the present invention; FIG. 3 is a partial enlarged view of a self-expanding stent according to an embodiment of the present invention; Schematic;
图 5为本发明实施例提供的载药槽二结构示意图; 图 6为本发明实施例提供的载药槽三结构示意图; FIG. 5 is a schematic structural view of a drug-loading tank according to an embodiment of the present invention; FIG. FIG. 6 is a schematic structural view of a three drug loading tank according to an embodiment of the present invention; FIG.
图 7为本发明实施例提供的载药层结构示意图。  FIG. 7 is a schematic structural view of a drug loading layer according to an embodiment of the present invention.
具体实施方式 本发明公开了一种自扩张支架,以解决环设计的自膨胀式支架支 撑力不均的问题, 避免植入后引起的组织增生和再狭窄出现。 DETAILED DESCRIPTION OF THE INVENTION The present invention discloses a self-expanding stent to solve the problem of uneven support of the self-expanding stent of the ring design, and to avoid tissue hyperplasia and restenosis caused by implantation.
下面将结合本发明实施例中的附图,对本发明实施例中的技术方 案进行清楚、 完整地描述, 显然, 所描述的实施例仅仅是本发明一部 分实施例, 而不是全部的实施例。 基于本发明中的实施例, 本领域普 通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例, 都属于本发明保护的范围。  The technical solutions in the embodiments of the present invention are clearly and completely described in the following with reference to the accompanying drawings in the embodiments of the present invention. It is obvious that the described embodiments are only a part of the embodiments of the present invention, but not all embodiments. All other embodiments obtained by a person skilled in the art based on the embodiments of the present invention without creative efforts are within the scope of the present invention.
请参阅图 2, 图 3, 图 2为本发明实施例提供的自扩张支架植入 脑动脉中的示意图,图 3为本发明实施例提供的自扩张支架的局部放 大图。  Referring to FIG. 2, FIG. 3, FIG. 2 is a schematic diagram of a self-expanding stent implanted in a cerebral artery according to an embodiment of the present invention, and FIG. 3 is a partial enlarged view of the self-expanding stent according to an embodiment of the present invention.
其中, 3为自扩张支架, 31为网孔, 32为支架杆件。  Among them, 3 is a self-expanding stent, 31 is a mesh, and 32 is a stent rod.
本发明提供的自扩张支架 3为镂空管状的网孔结构;  The self-expanding stent 3 provided by the invention is a hollow tubular mesh structure;
网孔 31周围为支架杆件 32;  Around the mesh 31 is a bracket member 32;
每一个支架杆件 32都能与相邻支架杆件形成闭合的网孔 31。 该支架为均一连续闭合的网孔结构, 均匀连续地覆盖狭窄斑块, 提供均一的环状支撑力, 特别是在弯曲的血管处, 闭合能够形成连续 的管腔通道,克服了开环式结构在弯曲处杆件的向血管壁伸张造成机 械刺激及向血管管腔内凸出造成再狭窄。  Each of the bracket members 32 can form a closed mesh 31 with an adjacent bracket member. The stent is a uniformly continuous closed mesh structure, uniformly and continuously covering the narrow plaque, providing a uniform annular supporting force, especially at the curved blood vessel, and closing can form a continuous lumen channel, overcoming the open loop structure The extension of the rod to the vessel wall at the bend causes mechanical stimulation and bulging into the lumen of the vessel causing restenosis.
单一闭合网孔 31 的结构可以为多边形, 优化的选择为三, 四, 五或六边形, 进一步为了受力更加均匀, 令网孔 31为等边形。  The structure of the single closed mesh 31 may be a polygon, and the optimized selection is three, four, five or hexagonal, and further, in order to make the force more uniform, the mesh 31 is equilateral.
进一步为了优化上述技术方案, 网孔 31沿支架 3的轴向长度小 于沿支架 3的径向长度,这样有利于保持支架 3在弯曲血管处的圓形 管腔通道。  Further, in order to optimize the above technical solution, the length of the mesh 31 along the axial direction of the stent 3 is smaller than the radial length along the stent 3, which is advantageous for maintaining the circular lumen passage of the stent 3 at the curved blood vessel.
支架 3的材料采用弹性记忆材料, 进一步可为温敏性记忆合金,  The material of the bracket 3 is made of an elastic memory material, and further may be a temperature-sensitive memory alloy.
4 温敏性弹性聚合物, 可被束缚于微细单腔管内, 被输送至靶病变处释 放, 在体温下可以恢复至束缚前尺寸。 4 The temperature-sensitive elastic polymer, which can be bound to a micro-single lumen, is delivered to the target lesion for release and can be restored to its pre-constrained size at body temperature.
综上所述, 本发明公开的治疗脑血管狭窄病变的支架 3, 动脉自 扩张支架为镂空管状, 均一网孔结构; 支架采用弹性记忆材料, 可被 压缩束缚于微细单腔管内, 被输送至脑血管病变处, 通过输送杆释放 狭窄病变处,扩张病变,重建血管流通道; 支架单侧外层具有载药层, 向血管壁内释放药物抑制再狭窄。 且均一连续闭合的网孔结构, 每一 个杆件都能与相邻杆件形成闭合的网孔, 均勾连续地覆盖狭窄斑块, 提供均一的环状支撑力, 特别是在弯曲的血管处, 闭合能够形成连续 的管腔通道,克服了开发式结构在弯曲处杆件的向血管壁伸张造成机 械刺激及向血管管腔内凸出造成狭窄。  In summary, the stent 3 for treating cerebrovascular stenosis disclosed in the present invention has an open tubular shape and a uniform mesh structure; the stent adopts an elastic memory material and can be compressed and bound in a micro single lumen tube, and is transported to At the cerebral vascular lesion, the stenotic lesion is released through the delivery rod, the lesion is expanded, and the vascular flow channel is reconstructed; the unilateral outer layer of the stent has a drug-loading layer, and the drug is released into the blood vessel wall to inhibit restenosis. And a uniformly closed mesh structure, each of the rods can form a closed mesh with the adjacent rods, and the hooks continuously cover the narrow plaques, providing a uniform annular supporting force, especially at the curved blood vessels. The closure can form a continuous lumen channel, overcoming the developmental structure causing mechanical stimulation at the bending of the rod to the vessel wall and causing stenosis to protrude into the lumen of the vessel.
请参阅图 4-8,图 4为本发明实施例提供的载药槽一结构示意图, 图 5为本发明实施例提供的载药槽二结构示意图,图 6为本发明实施 例提供的载药槽三结构示意图,图 7为本发明实施例提供的载药层结 构示意图。  Referring to FIG. 4-8, FIG. 4 is a schematic structural view of a drug-loading tank according to an embodiment of the present invention, FIG. 5 is a schematic structural view of a drug-loading tank provided by an embodiment of the present invention, and FIG. 6 is a drug-loading provided by an embodiment of the present invention. FIG. 7 is a schematic structural view of a drug loading layer according to an embodiment of the present invention.
其中, 321为载药槽基部, 4为载药槽结构, 41为表面封装层, 42为载药涂层, 43为结合层。  Wherein, 321 is the base of the drug-loading tank, 4 is a drug-loading tank structure, 41 is a surface encapsulating layer, 42 is a drug-loading coating layer, and 43 is a bonding layer.
支架杆件面向血管壁的外表面设有载药槽;其中载药槽结构 4可 以为沿支架杆件轴向的单一槽、 沿支架杆件轴向的多个槽, 垂直于支 架杆件德多个槽。  The outer surface of the stent rod facing the blood vessel wall is provided with a drug-loading groove; wherein the drug-loading groove structure 4 can be a single groove along the axial direction of the stent rod, and a plurality of grooves along the axial direction of the stent rod member, perpendicular to the stent rod member Multiple slots.
所述载药槽内设有药物层。 药物层具体包括结合层 43、 载药涂 层 42和表面封装层 41 ;  A drug layer is disposed in the drug loading tank. The drug layer specifically includes a bonding layer 43, a drug-loading coating layer 42 and a surface encapsulating layer 41;
所述结合层 43位于该药物层的底部,即设在载药槽基部 321上; 所述载药层 42位于所述结合层 43的上部;  The bonding layer 43 is located at the bottom of the drug layer, that is, on the drug carrier base 321; the drug loading layer 42 is located at the upper portion of the bonding layer 43;
所述表面封装层 41位于所述载药层 42的上部,且其外表面与支 架表面齐平。  The surface encapsulation layer 41 is located at an upper portion of the drug-loading layer 42 and has an outer surface that is flush with the surface of the support.
药物层用于向靶向血管壁内释放药物抑制平滑肌增生,支架与血 液接触的内表面仍为支架基体材料, 具有非常好的血液相容性, 避免 了由于药物涂层所引发的血栓和内皮化障碍。 载药层 42为局部凹入支架表面, 以克服该自扩张支架在单腔管 中输送时, 支架外壁与管内壁摩擦接触导致载药层破损或脱落。 药物 层均匀分布排列于支架杆件上,在覆盖血管壁范围形成均匀地覆盖空 间。 The drug layer is used to release the drug into the targeted vessel wall to inhibit smooth muscle hyperplasia. The inner surface of the stent in contact with the blood is still the scaffold matrix material, which has very good blood compatibility and avoids thrombus and endothelium caused by the drug coating. Barriers. The drug-loading layer 42 is partially recessed into the surface of the stent to overcome the frictional contact between the outer wall of the stent and the inner wall of the tube when the self-expanding stent is transported in the single-lumen tube, thereby causing damage or falling off of the drug-loading layer. The drug layer is evenly distributed on the stent rod to form a uniform coverage space covering the vessel wall.
位于药物层底部的结合层 43 具有微纳米不平结构, 如孔洞或 matrics结果, 目的是加强载药层 42在载药槽基部 321上的附着力; 位于结合层 43上部的载药层 42, 采用可降解高分子共混抑制增生的 药物;位于载药层 42上部的表面封装层 41,为一种亲水性润滑涂层, 以减小外层与输送单腔管内层的摩擦,提供输送能力,支架被植入后, 表面封装层 41融于组织液中, 暴露载药涂层 42。  The bonding layer 43 at the bottom of the drug layer has a micro-nano uneven structure, such as a hole or matrics result, for the purpose of enhancing the adhesion of the drug-loading layer 42 on the drug-carrying base 321; the drug-loading layer 42 located at the upper portion of the bonding layer 43 is used. The degradable polymer blend inhibits the proliferation of the drug; the surface encapsulating layer 41 located on the upper portion of the drug-loading layer 42 is a hydrophilic lubricating coating to reduce the friction between the outer layer and the inner layer of the transporting single-chamber tube, and provide the conveying ability After the stent is implanted, the surface encapsulation layer 41 is fused in the tissue fluid to expose the drug-loaded coating 42.
本发明主要用于血管病变导致的血管狭窄问题,尤其适用于脑动 脉的狭窄病变。  The invention is mainly used for the problem of blood vessel stenosis caused by vascular disease, and is especially suitable for stenosis of brain arteries.
本说明书中各个实施例采用递进的方式描述,每个实施例重点说 明的都是与其他实施例的不同之处,各个实施例之间相同相似部分互 相参见即可。  The various embodiments in the specification are described in a progressive manner, and each embodiment focuses on differences from other embodiments, and the same similar parts may be referred to each other.
对所公开的实施例的上述说明,使本领域专业技术人员能够实现 或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来 说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的 精神或范围的情况下, 在其它实施例中实现。 因此, 本发明将不会被 限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新 颖特点相一致的最宽的范围。  The above description of the disclosed embodiments enables those skilled in the art to make or use the invention. Various modifications to these embodiments are obvious to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the invention. Therefore, the present invention is not intended to be limited to the embodiments shown herein, but is to be accorded to the broadest scope of the principles and novel features disclosed herein.
6 6

Claims

权利要求 Rights request
1、 一种自扩张支架, 其特征在于, 该支架为镂空管状的网孔结 构; A self-expanding stent, characterized in that the stent is a hollow tubular mesh structure;
所述网孔周围为支架杆件;  Around the mesh is a bracket rod;
所述每一个支架杆件都能与相邻支架杆件形成闭合的网孔。  Each of the bracket members can form a closed mesh with an adjacent bracket member.
2、 如权利要求 1所述的自扩张支架, 其特征在于, 所述网孔为 多边形结构。 2. The self-expanding stent of claim 1, wherein the mesh is a polygonal structure.
■ 3、 如权利要求 2所述的自扩张支架, 其特征在于, 所述网孔为 三、 四、 五或六边形结构。 The self-expanding stent according to claim 2, wherein the mesh is a three-, four-, five- or six-sided structure.
4、 如权利要求 2或 3所述的自扩张支架, 其特征在于, 所述网 孔为等边多边形结构。 The self-expanding stent according to claim 2 or 3, wherein the mesh is an equilateral polygonal structure.
5、 如权利要求 1所述的自扩张支架, 其特征在于, 所述网孔沿 支架的轴向长度小于沿支架的径向长度。 5. The self-expanding stent of claim 1 wherein the mesh has a length along the axial direction of the stent that is less than a radial extent along the stent.
6、 如权利要求 1所述的自扩张支架, 其特征在于, 该支架采用 弹性记忆材料。 6. The self-expanding stent of claim 1 wherein the stent is of an elastic memory material.
7、 如权利要求 6所述的自扩张支架, 其特征在于, 该支架采用 温敏性记忆合金材料。 7. The self-expanding stent of claim 6 wherein the stent is a temperature sensitive memory alloy material.
8、 如权利要求 1所述的自扩张支架, 其特征在于, 所述支架杆 件面向血管壁的外表面设有药物层。 The self-expanding stent according to claim 1, wherein the stent rod is provided with a drug layer facing the outer surface of the blood vessel wall.
9、 如权利要求 8所述的自扩张支架, 其特征在于, 所述支架杆 件面向血管壁的外表面设有载药槽; 9. The self-expanding stent of claim 8, wherein the stent rod a drug-loading groove is arranged on an outer surface of the blood vessel wall;
所述药物层设于所述载药槽内。  The drug layer is disposed in the drug loading tank.
10、 如权利要求 8或 9所述的自扩张支架, 其特征在于, 所述药 物层具体包括结合层、 载药涂层和表面封装层; The self-expanding stent according to claim 8 or 9, wherein the drug layer specifically comprises a bonding layer, a drug-loading coating layer and a surface encapsulating layer;
所述结合层位于药物层的底部;  The bonding layer is located at the bottom of the drug layer;
所述载药层位于所述结合层的上部;  The drug loading layer is located at an upper portion of the bonding layer;
所述表面封装层位于所述载药层的上部,且其外表面与支架表面 齐平。  The surface encapsulation layer is located at an upper portion of the drug-loading layer, and an outer surface thereof is flush with a surface of the stent.
11、 如权利要求 10所述的自扩张支架, 其特征在于, 所述结合 层具有微纳米不平结构。 The self-expanding stent according to claim 10, wherein the bonding layer has a micro-nano uneven structure.
12、 如权利要求 10所述的自扩张支架, 其特征在于, 所述载药 层为可降解高分子共混抑制增生的药物。 The self-expanding stent according to claim 10, wherein the drug-loading layer is a drug that inhibits proliferation by degradable polymer blending.
13、 如权利要求 10所述的自扩张支架, 其特征在于, 所述表面 封装层为一种亲水性润滑涂层。 13. The self-expanding stent of claim 10, wherein the surface encapsulating layer is a hydrophilic lubricating coating.
14、 如权利要求 9所述的自扩张支架, 其特征在于, 所述载药槽 为沿杆件的单一槽、 沿杆件的多个槽或垂直杆件的多个槽 。 14. The self-expanding stent of claim 9, wherein the drug-loading trough is a single trough along the rod, a plurality of grooves along the rod or a plurality of grooves of the vertical rod.
15、 如权利要求 1所述的自扩张支架, 其特征在于, 该支架用于 脑动脉中。 15. The self-expanding stent of claim 1 wherein the stent is for use in a cerebral artery.
8 8
PCT/CN2010/080504 2009-12-30 2010-12-30 Self-expanding stent WO2011079806A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200910248068.0 2009-12-30
CN2009102480680A CN102113927A (en) 2009-12-30 2009-12-30 Self-expanded stent

Publications (1)

Publication Number Publication Date
WO2011079806A1 true WO2011079806A1 (en) 2011-07-07

Family

ID=44212930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2010/080504 WO2011079806A1 (en) 2009-12-30 2010-12-30 Self-expanding stent

Country Status (2)

Country Link
CN (1) CN102113927A (en)
WO (1) WO2011079806A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102626528A (en) * 2012-04-16 2012-08-08 上海交通大学 Gradually-expanding intravascular stent
CN111839849A (en) * 2020-07-17 2020-10-30 易浦润(上海)生物技术有限公司 Urethral stent and preparation method and application thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356423A (en) * 1991-01-04 1994-10-18 American Medical Systems, Inc. Resectable self-expanding stent
US6315791B1 (en) * 1996-12-03 2001-11-13 Atrium Medical Corporation Self-expanding prothesis
US20020038146A1 (en) * 1998-07-29 2002-03-28 Ulf Harry Expandable stent with relief cuts for carrying medicines and other materials
US6805898B1 (en) * 2000-09-28 2004-10-19 Advanced Cardiovascular Systems, Inc. Surface features of an implantable medical device
CN1593355A (en) * 2004-07-12 2005-03-16 哈尔滨工业大学 Non-homogeneous pharmaceutical elution supporting stand
US20060235503A1 (en) * 2001-05-07 2006-10-19 Cordis Corporation Local drug delivery devices and methods for maintaining the drug coatings thereon
US20070123974A1 (en) * 2005-10-24 2007-05-31 Samsung Life Welfare Foundation Vascular stent which is specially designed for the multiple drug loading and better drug elution
CN101370448A (en) * 2006-01-30 2009-02-18 东洋先进机床有限公司 Stent and process for producing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2503865Y (en) * 2001-08-01 2002-08-07 蒲忠杰 Medicine released support

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356423A (en) * 1991-01-04 1994-10-18 American Medical Systems, Inc. Resectable self-expanding stent
US6315791B1 (en) * 1996-12-03 2001-11-13 Atrium Medical Corporation Self-expanding prothesis
US20020038146A1 (en) * 1998-07-29 2002-03-28 Ulf Harry Expandable stent with relief cuts for carrying medicines and other materials
US6805898B1 (en) * 2000-09-28 2004-10-19 Advanced Cardiovascular Systems, Inc. Surface features of an implantable medical device
US20060235503A1 (en) * 2001-05-07 2006-10-19 Cordis Corporation Local drug delivery devices and methods for maintaining the drug coatings thereon
CN1593355A (en) * 2004-07-12 2005-03-16 哈尔滨工业大学 Non-homogeneous pharmaceutical elution supporting stand
US20070123974A1 (en) * 2005-10-24 2007-05-31 Samsung Life Welfare Foundation Vascular stent which is specially designed for the multiple drug loading and better drug elution
CN101370448A (en) * 2006-01-30 2009-02-18 东洋先进机床有限公司 Stent and process for producing the same

Also Published As

Publication number Publication date
CN102113927A (en) 2011-07-06

Similar Documents

Publication Publication Date Title
JP6606578B2 (en) Endoprosthesis
US8652201B2 (en) Apparatus and method for treating cardiovascular diseases
US9114035B2 (en) Apparatus and method for treating cardiovascular diseases
JP5536637B2 (en) Intravascular device with net system
US20160015541A1 (en) Highly flexible stent
US20030078647A1 (en) Angioplasty stent adapted to counter restenosis, respective kit and components
JP5752658B2 (en) Intraluminal medical device having axial flexibility that varies around
JP2008501480A (en) Stent with protruding branch for branch pipe
WO2016173553A1 (en) Support and drug delivery device
WO2011131115A1 (en) Stent for bifurcated vessel
EP1374799A1 (en) Hemodynamic luminal endoprosthesis
CN112354070A (en) Preparation method of medicine balloon and medicine balloon prepared by preparation method
JP5217026B2 (en) Stent and manufacturing method thereof
WO2011079806A1 (en) Self-expanding stent
CN203379235U (en) Pulmonary artery support and pulmonary artery valve replacement device with thereof
CN202740162U (en) Novel vessel rack
WO2009052703A1 (en) Nested stent in body lumen
EP4066794A1 (en) Knitted stent and knitted stent system
US9795772B2 (en) Endoluminal drug delivery device
CN209827116U (en) Recyclable medicine support
WO2016026235A1 (en) Biodegradable drug stent
CN201168080Y (en) Repeatedly-usable stent for human body lumens
CN112263360A (en) In vivo drug eluting stent and preparation method thereof
JP2006247139A (en) Method of manufacturing stent and stent
CN110464519A (en) A kind of balloon-stent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10840593

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10840593

Country of ref document: EP

Kind code of ref document: A1